ARCHIVES

Trading In Stock Of U.S. Bioscience Halted, Newsletter Report Cited

This article is from The Cancer Letter archive.

Vol. 18 No. 39 | October 9, 1992

Download PDF Visit The Full Archive

Related Articles

NCAB To Hear Program Reviews, Try Again On Act Revisions

October 22, 1976

House Encourages NCI To continue Leadership Role As Coordinator Of Cancer Program

October 8, 1999

Statistical Models Determine Stem-Cell Transplant Effectiveness

July 26, 2013

FDA Advisors Ok Marketing Of Taxotere As Treatment For Advanced Breast Cancer

October 20, 1995

Judge Rules FDA Can’t Enforce Pediatric Rule

October 25, 2002

At Its Launch, STAR Trial Inherits Baggage Of Its Predecessor, P-1 Tamoxifin Study

June 4, 1999